Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 20,000 shares at $22.68 ($454K) on 2014-11-17, disclosed to the SEC on 2014-11-19.
Scheduled sale ($454k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |